163 related articles for article (PubMed ID: 7481246)
1. [Compliance with hormone replacement therapy].
Rozenberg S; Vandromme J; Kroll M; Twagirayezu P; Vyankandondera J
Rev Med Brux; 1995; 16(4):295-8. PubMed ID: 7481246
[TBL] [Abstract][Full Text] [Related]
2. Compliance to hormone replacement therapy.
Rozenberg S; Vandromme J; Kroll M; Pastijn A; Liebens F
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586
[TBL] [Abstract][Full Text] [Related]
3. Compliance considerations with hormone replacement therapy.
KarakoƧ B; Erenus M
Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
5. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
Perrone G; Capri O; Borrello M; Galoppi P
Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
[TBL] [Abstract][Full Text] [Related]
6. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
Neuner JM; McCarthy EP; Davis RB; Phillips RS
J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
[TBL] [Abstract][Full Text] [Related]
7. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal osteoporosis and hormone replacement therapy.
Gambacciani M; Vacca F
Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
[TBL] [Abstract][Full Text] [Related]
9. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
[TBL] [Abstract][Full Text] [Related]
10. Low-dose hormone replacement therapy: effects on bone.
Gambacciani M; Monteleone P; Genazzani AR
Climacteric; 2002 Jun; 5(2):135-9. PubMed ID: 12051108
[TBL] [Abstract][Full Text] [Related]
11. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
12. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
Saver BG; Taylor TR; Woods NF
J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
14. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
Haskell SG
J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
[TBL] [Abstract][Full Text] [Related]
15. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
[TBL] [Abstract][Full Text] [Related]
16. [Reflections on compliance in menopause hormone replacement therapy].
Berthet J; Tabaste JL; Vendittelli F
Rev Fr Gynecol Obstet; 1995 Dec; 90(12):548-51. PubMed ID: 8677410
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
19. Climacteric: concept, consequence and care.
Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]